Arpa Garay

CIK 1916360 · View on SEC EDGAR ↗

Insider

First SEC filing: June 29, 2022 · Latest: June 29, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 18 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

18 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 6, 2023 MRNA S 564 $78.34 $44,184 3,690 Direct -13.26% Disposed 72.2% (price as of 2026-08-19)
Sept. 6, 2023 MRNA S 574 $108.40 $62,222 3,113 Direct -15.57% Disposed 24.5% (price as of 2026-08-19)
June 6, 2023 MRNA S 2,290 $125.75 $287,968 2,547 Direct -47.34% Disposed 7.3% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Dec. 5, 2023 MRNA Restricted Stock Units Common Stock (1,141) — — 1,141 Disposed
Sept. 5, 2023 MRNA Restricted Stock Units Common Stock (1,140) — — 1,140 Disposed
June 5, 2023 MRNA Restricted Stock Units Common Stock (4,562) — — 4,562 Disposed
Feb. 28, 2023 MRNA Restricted Stock Units Common Stock (5,260) $0.00 — 5,260 Acquired
Feb. 28, 2023 MRNA Stock Option (Right to Buy) Common Stock (20,040) $138.81 Feb. 28, 2033 20,040 Acquired
May 4, 2022 MRK Restricted Stock Unit Common Stock (907) — May 4, 2024 907 Disposed
May 3, 2022 MRK Stock Option (Right to Buy) Common Stock (21,359) $87.10 May 2, 2032 21,359 Acquired
May 3, 2022 MRK Restricted Stock Unit Common Stock (773) — May 3, 2022 773 Disposed
May 1, 2022 MRK Restricted Stock Unit Common Stock (866) — May 1, 2023 866 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 11 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 29, 2022 MRNA Stock Option (Right to Buy)→ Common Stock (34,766) 34,766 Direct
June 29, 2022 MRNA Restricted Stock Units→ Common Stock (18,248) 18,248 Direct
March 10, 2022 MRK Common Stock 290 Direct
March 10, 2022 MRK Restricted Stock Unit→ Common Stock (773) 773 Direct
March 10, 2022 MRK Restricted Stock Unit→ Common Stock (1,732) 1,732 Direct
March 10, 2022 MRK Restricted Stock Unit→ Common Stock (1,828) 1,828 Direct
March 10, 2022 MRK Restricted Stock Unit→ Common Stock (2,726) 2,726 Direct
March 10, 2022 MRK Restricted Stock Unit→ Common Stock (13,087) 13,087 Direct
March 10, 2022 MRK Stock Option (Right to Buy)→ Common Stock (5,821) 5,821 Direct
March 10, 2022 MRK Stock Option (Right to Buy)→ Common Stock (13,543) 13,543 Direct
March 10, 2022 MRK Stock Option (Right to Buy)→ Common Stock (21,139) 21,139 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

MRNA

Chief Commercial Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2023 $842,308 — — — $619,650 — $63,413 $4,445,948
2022 $458,462 $1,500,000 — — $508,932 — $203,303 $7,676,152

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.